Axoguard HA+ Nerve Protector
Device
AXOGEN
Total Payments
$117,547
Transactions
28
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $115,087 | 27 | 0 |
| 2023 | $2,460 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $108,951 | 27 | 92.7% |
| Grant | $8,596 | 1 | 7.3% |
Payments by Type
Research
$108,951
27 transactions
General
$8,596
1 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Nerve Protection Evaluation: Revision Cubital Tunnel Syndrome Decompression (COVERED) | AXOGEN | $108,951 | 0 |
Top Doctors Receiving Payments for Axoguard HA+ Nerve Protector
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Puyallup, WA | $117,547 | 28 |
About Axoguard HA+ Nerve Protector
Axoguard HA+ Nerve Protector is a device associated with $117,547 in payments to 0 healthcare providers, recorded across 28 transactions in the CMS Open Payments database. The primary manufacturer is AXOGEN.
Payment data is available from 2023 to 2024. In 2024, $115,087 was paid across 27 transactions to 0 doctors.
The most common payment nature for Axoguard HA+ Nerve Protector is "Unspecified" ($108,951, 92.7% of total).
Axoguard HA+ Nerve Protector is associated with 1 research study, including "Nerve Protection Evaluation: Revision Cubital Tunnel Syndrome Decompression (COVERED)" ($108,951).